|
JPS5875614A
(ja)
*
|
1981-10-28 |
1983-05-07 |
Matsushita Electric Ind Co Ltd |
焼却炉の排ガス浄化装置
|
|
DE4312016A1
(de)
*
|
1993-04-13 |
1994-10-20 |
Goedecke Ag |
Stabile Ketamin-Lösungen
|
|
DE19619665C2
(de)
*
|
1996-05-15 |
2001-03-08 |
Goedecke Ag |
Racemattrennung von Ketamin
|
|
BRPI0002693B8
(pt)
*
|
2000-06-19 |
2021-05-25 |
Cristalia Produtos Quim Farmaceuticos Ltda |
processo de obtenção dos enantiômeros da cetamina e seus sais farmaceuticamente aceitáveis
|
|
US7273889B2
(en)
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
|
US9072662B2
(en)
|
2004-03-29 |
2015-07-07 |
Auris Medical Ag |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
US8268866B2
(en)
|
2004-03-29 |
2012-09-18 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
US20060063802A1
(en)
|
2004-03-29 |
2006-03-23 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
CA2620374C
(en)
|
2005-09-28 |
2012-12-11 |
Thomas Meyer |
Pharmaceutical compositions for the treatment of inner ear disorders
|
|
ES2862673T3
(es)
|
2011-12-12 |
2021-10-07 |
Zilentin AG |
Tratamiento del tinnitus mediante la modulación del cotransportador de cloruro NKCC1 en el sistema auditivo
|
|
US20140274981A1
(en)
|
2013-03-15 |
2014-09-18 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition of s-ketamine hydrochloride
|
|
DK3043785T3
(da)
|
2013-09-13 |
2021-11-15 |
Univ Chiba Nat Univ Corp |
Anvendelse af r-ketamin og salt deraf som lægemidler
|
|
US10098854B2
(en)
|
2014-08-13 |
2018-10-16 |
Janssen Pharmaceutica Nv |
Method for the treatment of depression
|
|
EP3193853A1
(de)
|
2014-09-15 |
2017-07-26 |
Janssen Pharmaceutica NV |
Val66met (snp rs6265) genotypspezifische dosierschemata und verfahren zur behandlung von depression
|
|
US20160332962A1
(en)
*
|
2015-05-13 |
2016-11-17 |
Janssen Pharmaceutica Nv |
(s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
|
|
US20200009081A1
(en)
|
2017-09-13 |
2020-01-09 |
Janssen Pharmaceutica N.V. |
Delivery Of Esketamine For The Treatment Of Depression
|
|
SG11202005896WA
(en)
|
2017-12-22 |
2020-07-29 |
Janssen Pharmaceuticals Inc |
Esketamine for the treatment of depression
|
|
WO2019160057A1
(ja)
|
2018-02-15 |
2019-08-22 |
国立大学法人千葉大学 |
炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物
|
|
CN110218157B
(zh)
*
|
2018-03-01 |
2022-08-23 |
江苏恒瑞医药股份有限公司 |
一种r-氯胺酮及其可药用盐的制备方法
|
|
CN118121577A
(zh)
|
2018-05-04 |
2024-06-04 |
感知神经科学公司 |
治疗物质滥用的方法
|
|
CA3103440A1
(en)
|
2018-06-27 |
2020-01-02 |
Clexio Biosciences Ltd. |
Method of treating major depressive disorder
|
|
WO2020070706A1
(en)
|
2018-10-05 |
2020-04-09 |
Clexio Biosciences Ltd. |
Dosage regime of esketamine for treating major depressive disorder
|
|
WO2020070547A1
(en)
|
2018-10-05 |
2020-04-09 |
Clexio Biosciences Ltd. |
Dosage regime of esketamine for treating major depressive disorder
|
|
WO2020075134A1
(en)
|
2018-10-11 |
2020-04-16 |
Clexio Biosciences Ltd. |
Esketamine for use in treating major depressive disorder
|
|
EP3934632A4
(de)
|
2019-03-05 |
2022-11-23 |
Janssen Pharmaceuticals, Inc. |
Esketamin zur behandlung von depression
|
|
JP2023507926A
(ja)
|
2019-12-30 |
2023-02-28 |
クレキシオ バイオサイエンシーズ エルティーディー． |
神経精神状態または神経学的状態を治療するためのエスケタミンを用いた投与計画
|
|
WO2021137147A1
(en)
|
2019-12-30 |
2021-07-08 |
Clexio Biosciences Ltd. |
Dosage regime with esketamine for treating major depressive disorder
|
|
PH12022551856A1
(en)
|
2020-01-22 |
2024-01-03 |
Seelos Therapeutics Inc |
Reducing side effects of nmda antagonists
|
|
CN112125816A
(zh)
*
|
2020-03-17 |
2020-12-25 |
国药集团工业有限公司 |
一种氯胺酮、其衍生物或其盐的消旋化方法
|
|
US20250082587A1
(en)
|
2023-09-12 |
2025-03-13 |
Clexio Biosciences Ltd. |
Method Of Treating Major Depressive Disorder
|